|
US397782A
(en)
*
|
|
1889-02-12 |
|
Plunger water-closet |
|
NL254871A
(https=)
|
1959-08-14 |
|
|
|
|
US3939169A
(en)
*
|
1971-03-29 |
1976-02-17 |
Imperial Chemical Industries Limited |
Alkylene bis(pyridiniumareylene quaternary salts)
|
|
GB1339764A
(en)
*
|
1971-03-29 |
1973-12-05 |
Ici Ltd |
Pyridine derivatives
|
|
DE2942930A1
(de)
|
1979-10-24 |
1981-05-27 |
Basf Ag, 6700 Ludwigshafen |
Substituierte harnstoffe, deren herstellung und verwendung als herbizide
|
|
DE3147879A1
(de)
|
1981-12-03 |
1983-06-16 |
Basf Ag, 6700 Ludwigshafen |
1,3,5-triazinone, verfahren zu ihrer herstellung und ihre verwendung zur bekaempfung unerwuenschten pflanzenwuchses
|
|
DE3271848D1
(en)
|
1981-12-03 |
1986-07-31 |
Basf Ag |
1,3,5-triazinones, process for their preparation and their use in combating undesired plant growth
|
|
WO1984003884A1
(en)
|
1983-03-29 |
1984-10-11 |
Fmc Corp |
N-phenyl-n'-(pyridinyl-n-oxide)urea plant regulators
|
|
US4787931A
(en)
*
|
1984-03-06 |
1988-11-29 |
Fmc Corporation |
N-phenyl-N'-(pyridinyl-N-oxide)urea plant regulators
|
|
US4672066A
(en)
*
|
1985-04-22 |
1987-06-09 |
Hoffmann-La Roche Inc. |
Derivatives of 4-acetyl-3-hydroxy-2-alkyl-phenoxycarboxylic acids
|
|
GB9027023D0
(en)
|
1990-12-12 |
1991-01-30 |
Wellcome Found |
Anti-atherosclerotic aryl compounds
|
|
US5162360A
(en)
*
|
1991-06-24 |
1992-11-10 |
Warner-Lambert Company |
2-heteroatom containing urea and thiourea ACAT inhibitors
|
|
GB9201180D0
(en)
|
1992-01-21 |
1992-03-11 |
Glaxo Group Ltd |
Chemical compounds
|
|
AU4028393A
(en)
*
|
1992-05-28 |
1993-12-30 |
Pfizer Inc. |
New (N)-aryl and (N)-heteroarylurea derivatives as inhibitors of acyl coenzyme a:cholesterol acyl transferase (ACAT)
|
|
ES2051647B1
(es)
|
1992-12-10 |
1995-01-16 |
Lipotec Sa |
Procedimiento para la preparacion de calcitonina de salmon.
|
|
GB9304920D0
(en)
*
|
1993-03-10 |
1993-04-28 |
Celltech Ltd |
Chemical compounds
|
|
EP0634402A1
(en)
*
|
1993-07-14 |
1995-01-18 |
Takeda Chemical Industries, Ltd. |
Isochinolinone derivatives, their production and use
|
|
US5547966A
(en)
*
|
1993-10-07 |
1996-08-20 |
Bristol-Myers Squibb Company |
Aryl urea and related compounds
|
|
KR970706242A
(ko)
|
1994-10-04 |
1997-11-03 |
후지야마 아키라 |
우레아 유도체 및 ACAT-억제제로서 그의 용도(Urea derivatives and their use as ACAT-inhibitors)
|
|
ES2218554T3
(es)
*
|
1994-10-27 |
2004-11-16 |
Fujisawa Pharmaceutical Co., Ltd. |
Piridopirimidonas, quinolinas y n-heterociclos condensados que son antagonistas de bradiquinina.
|
|
US6010026A
(en)
|
1994-11-22 |
2000-01-04 |
Aluminum Company Of America |
Assembly of aluminum can and threaded sleeve
|
|
US5556969A
(en)
*
|
1994-12-07 |
1996-09-17 |
Merck Sharp & Dohme Ltd. |
Benzodiazepine derivatives
|
|
US5624937A
(en)
*
|
1995-03-02 |
1997-04-29 |
Eli Lilly And Company |
Chemical compounds as inhibitors of amyloid beta protein production
|
|
GB9504361D0
(en)
*
|
1995-03-04 |
1995-04-26 |
Glaxo Spa |
Heterocyclic compounds
|
|
GB9511355D0
(en)
|
1995-06-06 |
1995-08-02 |
Fujisawa Pharmaceutical Co |
Urea derivatives
|
|
US5972975A
(en)
*
|
1995-12-08 |
1999-10-26 |
Merck & Co., Inc. |
Substituted 2-aminopyridines as inhibitors of nitric oxide synthase
|
|
US6005008A
(en)
*
|
1996-02-16 |
1999-12-21 |
Smithkline Beecham Corporation |
IL-8 receptor antagonists
|
|
ATE230403T1
(de)
*
|
1996-07-23 |
2003-01-15 |
Neurogen Corp |
Einige amido- und ammo- substituierte benzylaminderivate: eine neue klasse von neuropeptid y1 spezifische ligande
|
|
IT1284198B1
(it)
|
1996-07-30 |
1998-05-08 |
Beniamino Anzalone |
Carne vegetale
|
|
US6174905B1
(en)
*
|
1996-09-30 |
2001-01-16 |
Mitsui Chemicals, Inc. |
Cell differentiation inducer
|
|
AUPO390996A0
(en)
|
1996-11-29 |
1996-12-19 |
Fujisawa Pharmaceutical Co., Ltd. |
Urea derivatives
|
|
JP2002241368A
(ja)
|
1997-02-18 |
2002-08-28 |
Shionogi & Co Ltd |
新規ベンゾラクタム誘導体およびそれを含有する医薬組成物
|
|
WO1998041510A1
(en)
|
1997-03-14 |
1998-09-24 |
Shionogi & Co., Ltd. |
Novel benzolactam derivatives and medicinal compositions comprising the same
|
|
AU7526798A
(en)
|
1997-04-18 |
1998-11-27 |
Smithkline Beecham Plc |
Acetamide and urea derivatives, process for their preparation and their use in the treatment of cns disorders
|
|
DK0986382T3
(da)
|
1997-05-23 |
2008-10-20 |
Bayer Pharmaceuticals Corp |
RAF-kinasehæmmere
|
|
DE69826695T2
(de)
|
1997-05-23 |
2006-02-02 |
Bayer Pharmaceuticals Corp., West Haven |
Arylharnstoffderivate zur behandlung von inflammatorischen oder immunomodulatorischen erkrankungen
|
|
US6262083B1
(en)
*
|
1997-11-05 |
2001-07-17 |
Choongwae Pharma Corporation |
Genipin derivative having liver protection activity
|
|
ATE529109T1
(de)
|
1997-12-22 |
2011-11-15 |
Bayer Healthcare Llc |
Hemmung der p38 kinase aktivität durch substituierte heterocyclische harnstoffe
|
|
WO1999032463A1
(en)
|
1997-12-22 |
1999-07-01 |
Bayer Corporation |
INHIBITION OF p38 KINASE USING SYMMETRICAL AND UNSYMMETRICAL DIPHENYL UREAS
|
|
DE69831013T2
(de)
|
1997-12-22 |
2006-04-20 |
Bayer Pharmaceuticals Corp., West Haven |
Inhibierung der raf-kinase durch substituierte heterocyclische harnstoffverbindungen
|
|
US7517880B2
(en)
*
|
1997-12-22 |
2009-04-14 |
Bayer Pharmaceuticals Corporation |
Inhibition of p38 kinase using symmetrical and unsymmetrical diphenyl ureas
|
|
CN1213022C
(zh)
|
1997-12-22 |
2005-08-03 |
拜尔有限公司 |
用对称和不对称的取代二苯脲抑制raf激酶
|
|
JP4405602B2
(ja)
|
1998-04-16 |
2010-01-27 |
バイエル・シエーリング・ファーマ アクチエンゲゼルシャフト |
ヒストン脱アセチル化酵素阻害剤
|
|
US6329395B1
(en)
*
|
1998-06-08 |
2001-12-11 |
Schering Corporation |
Neuropeptide Y5 receptor antagonists
|
|
EP1086078B1
(en)
|
1998-06-08 |
2003-02-05 |
Schering Corporation |
Neuropeptide y5 receptor antagonists
|
|
US6407124B1
(en)
*
|
1998-06-18 |
2002-06-18 |
Bristol-Myers Squibb Company |
Carbon substituted aminothiazole inhibitors of cyclin dependent kinases
|
|
AU5065999A
(en)
*
|
1998-08-11 |
2000-03-06 |
Sumitomo Pharmaceuticals Company, Limited |
Naphthyridine derivatives
|
|
US6331541B1
(en)
|
1998-12-18 |
2001-12-18 |
Soo S. Ko |
N-ureidoalkyl-piperidines as modulators of chemokine receptor activity
|
|
JP2000256194A
(ja)
|
1999-01-06 |
2000-09-19 |
Mitsui Chemicals Inc |
核内レセプタ作動薬およびその効果増強剤
|
|
US7928239B2
(en)
*
|
1999-01-13 |
2011-04-19 |
Bayer Healthcare Llc |
Inhibition of RAF kinase using quinolyl, isoquinolyl or pyridyl ureas
|
|
EP1158985B1
(en)
|
1999-01-13 |
2011-12-28 |
Bayer HealthCare LLC |
OMEGA-CARBOXY ARYL SUBSTITUTED DIPHENYL UREAS AS p38 KINASE INHIBITORS
|
|
AU3707600A
(en)
*
|
1999-03-01 |
2000-09-21 |
Regents Of The University Of California, The |
Thiacrown polymers for removal of mercury from waste streams
|
|
EP1169038B9
(en)
*
|
1999-04-15 |
2013-07-10 |
Bristol-Myers Squibb Company |
Cyclic protein tyrosine kinase inhibitors
|
|
US6410254B1
(en)
|
1999-05-18 |
2002-06-25 |
Cytokinetics |
Compositions and assays utilizing ADP or phosphate for detecting protein modulators
|
|
DE19921498A1
(de)
*
|
1999-05-08 |
2000-11-16 |
Clariant Gmbh |
Verfahren zur Herstellung von wäßrigen Diazoniumsalzlösungen
|
|
CA2374737C
(en)
*
|
1999-07-09 |
2008-02-12 |
Boehringer Ingelheim Pharmaceuticals, Inc. |
Novel process for synthesis of heteroaryl-substituted urea compounds
|
|
CA2380389A1
(en)
|
1999-07-26 |
2001-02-01 |
Banyu Pharmaceutical Co., Ltd. |
Biarylurea derivatives
|
|
CA2385972A1
(en)
|
1999-10-01 |
2001-04-12 |
Haruhisa Ogita |
Novel diarylamide derivatives and use thereof as medicines
|
|
EP1232150B1
(en)
|
1999-11-16 |
2007-10-10 |
Boehringer Ingelheim Pharmaceuticals Inc. |
Urea derivatives as anti-inflammatory agents
|
|
HN2001000008A
(es)
*
|
2000-01-21 |
2003-12-11 |
Inc Agouron Pharmaceuticals |
Compuesto de amida y composiciones farmaceuticas para inhibir proteinquinasas, y su modo de empleo
|
|
JP2001278886A
(ja)
*
|
2000-03-28 |
2001-10-10 |
Dai Ichi Seiyaku Co Ltd |
ベンゾオキサジン誘導体及びこれを含有する医薬
|
|
US6495337B1
(en)
|
2000-03-29 |
2002-12-17 |
Cytokinetics, Inc. |
High throughput sarcomeric assay
|
|
CA2413274A1
(en)
|
2000-06-21 |
2001-12-27 |
George V. Delucca |
N-ureidoalkyl-piperidines as modulators of chemokine receptor activity
|
|
GB0015601D0
(en)
*
|
2000-06-26 |
2000-08-16 |
Ferring Bv |
Novel antidiuretic agents
|
|
GB0015904D0
(en)
|
2000-06-28 |
2000-08-23 |
Hoffmann La Roche |
Inhibitors of HPV E1 helicase enzyme
|
|
WO2002002521A2
(en)
*
|
2000-06-30 |
2002-01-10 |
Ortho-Mcneil Pharmaceutical, Inc. |
Aroyl aminoacyl pyrrole compounds and their pharmaceutical use
|
|
ES2291329T3
(es)
|
2000-07-18 |
2008-03-01 |
Dainippon Sumitomo Pharma Co., Ltd. |
Inhibidores de la recaptacion de serotonina.
|
|
GB0017676D0
(en)
|
2000-07-19 |
2000-09-06 |
Angeletti P Ist Richerche Bio |
Inhibitors of viral polymerase
|
|
US6645990B2
(en)
*
|
2000-08-15 |
2003-11-11 |
Amgen Inc. |
Thiazolyl urea compounds and methods of uses
|
|
US20020173507A1
(en)
|
2000-08-15 |
2002-11-21 |
Vincent Santora |
Urea compounds and methods of uses
|
|
US6573264B1
(en)
|
2000-10-23 |
2003-06-03 |
Cv Therapeutics, Inc. |
Heteroaryl alkyl piperazine derivatives
|
|
US7091353B2
(en)
*
|
2000-12-27 |
2006-08-15 |
Celgene Corporation |
Isoindole-imide compounds, compositions, and uses thereof
|
|
US20030045552A1
(en)
|
2000-12-27 |
2003-03-06 |
Robarge Michael J. |
Isoindole-imide compounds, compositions, and uses thereof
|
|
US6656971B2
(en)
*
|
2001-01-25 |
2003-12-02 |
Guilford Pharmaceuticals Inc. |
Trisubstituted carbocyclic cyclophilin binding compounds and their use
|
|
JP2002220338A
(ja)
|
2001-01-26 |
2002-08-09 |
Banyu Pharmaceut Co Ltd |
ビアリールウレア化合物又はその塩を有効成分として含有するＣｄｋ４及び／又はＣｄｋ６阻害剤
|
|
GB0117950D0
(en)
*
|
2001-02-16 |
2001-09-19 |
Aventis Pharma Inc |
Novel heterocyclic urea derivatives andd their use as dopamine D3 receptor ligands
|
|
DE10110749A1
(de)
|
2001-03-07 |
2002-09-12 |
Bayer Ag |
Substituierte Aminodicarbonsäurederivate
|
|
EP1379505B1
(en)
|
2001-04-20 |
2007-02-28 |
Bayer Pharmaceuticals Corporation |
Inhibition of raf kinase using quinolyl, isoquinolyl or pyridyl ureas
|
|
JP2004530690A
(ja)
|
2001-05-16 |
2004-10-07 |
ベーリンガー インゲルハイム ファーマシューティカルズ インコーポレイテッド |
抗炎症性薬剤として有用なジアリールウレア誘導体
|
|
EP1395561A1
(en)
*
|
2001-05-25 |
2004-03-10 |
Boehringer Ingelheim Pharmaceuticals Inc. |
Carbamate and oxamide compounds as inhibitors of cytokine production
|
|
WO2002099388A2
(en)
|
2001-06-07 |
2002-12-12 |
Merck & Co., Inc. |
Benzodiazepine bradykinin antagonists
|
|
WO2003005999A2
(en)
*
|
2001-07-11 |
2003-01-23 |
Boehringer Ingelheim Pharmaceuticals, Inc. |
Methods of treating cytokine mediated diseases
|
|
DE10134482A1
(de)
|
2001-07-16 |
2003-01-30 |
Bayer Ag |
Substituierte Isoindole und ihre Verwendung
|
|
AUPR688101A0
(en)
|
2001-08-08 |
2001-08-30 |
Luminis Pty Limited |
Protein domains and their ligands
|
|
WO2003022820A1
(en)
|
2001-09-06 |
2003-03-20 |
Bristol-Myers Squibb Pharma Company. |
Heteroaromatic substituted cyclopropane as corticotropin releasing hormone
|
|
CA2460149A1
(en)
|
2001-09-12 |
2003-03-27 |
Kaken Pharmaceutical Co., Ltd. |
2-phenyl-3-heteroarylpropionic acid derivative or salt thereof and medicine containing the same
|
|
US7320126B2
(en)
*
|
2001-11-06 |
2008-01-15 |
Sandisk Corporation |
Implementation of in system programming to update firmware on memory cards
|
|
TWI249515B
(en)
|
2001-11-13 |
2006-02-21 |
Theravance Inc |
Aryl aniline beta2 adrenergic receptor agonists
|
|
US6908923B2
(en)
|
2001-12-21 |
2005-06-21 |
Cytokinetics, Inc. |
Compositions and methods for treating heart failure
|
|
US20030207872A1
(en)
*
|
2002-01-11 |
2003-11-06 |
Bayer Corporation |
Omega-carboxyaryl substituted diphenyl ureas as raf kinase inhibitors
|
|
US7148236B2
(en)
|
2002-01-17 |
2006-12-12 |
Merck & Co., Inc. |
Modulators of acetylcholine receptors
|
|
US7408067B2
(en)
|
2002-01-17 |
2008-08-05 |
Merck + Co., Inc. |
Aza-cyclic compounds as modulators of acetylcholine receptors
|
|
SI1478358T1
(sl)
|
2002-02-11 |
2013-09-30 |
Bayer Healthcare Llc |
Sorafenib tozilat za zdravljenje bolezni, značilnih po abnormalni angiogenezi
|
|
DE10208986A1
(de)
|
2002-02-28 |
2003-09-11 |
Aventis Pharma Gmbh |
Verwendung substituierter 3-Phenyl-5-alkoxi-1,3,4-oxdiazol-2-one zur Herstellung von Arzneimitteln mit hemmender Wirkung an der pankreatischen Lipase
|
|
JP4471262B2
(ja)
|
2002-03-07 |
2010-06-02 |
株式会社エス・ディー・エス バイオテック |
置換イソキサゾールアルキルアミン誘導体及び農園芸用殺菌剤
|
|
DE60335175D1
(de)
|
2002-03-28 |
2011-01-13 |
Merck Serono Sa |
Thiazolidin-carbonsäureamid-derivate als modulatoren des prostaglandin-f-rezeptors
|
|
TW200400035A
(en)
|
2002-03-28 |
2004-01-01 |
Glaxo Group Ltd |
Novel compounds
|
|
AU2003220935A1
(en)
|
2002-04-03 |
2003-10-13 |
Sumitomo Pharmaceuticals Company, Limited. |
Benzamide derivatives
|
|
NZ535763A
(en)
|
2002-04-18 |
2007-06-29 |
Schering Corp |
(1-4-piperidinyl) benzimidazole derivatives useful as histamine H3 antagonists
|
|
US7105505B2
(en)
*
|
2002-04-18 |
2006-09-12 |
Schering Corporation |
Benzimidazole derivatives useful as histamine H3 antagonists
|
|
TW200306841A
(en)
|
2002-04-23 |
2003-12-01 |
Bristol Myers Squibb Co |
Aryl ketone pyrrolo-triazine compounds useful as kinase inhibitors
|
|
US20030236287A1
(en)
*
|
2002-05-03 |
2003-12-25 |
Piotrowski David W. |
Positive allosteric modulators of the nicotinic acetylcholine receptor
|
|
WO2003097574A2
(en)
|
2002-05-17 |
2003-11-27 |
Lica Pharmaceuticals A/S |
Aminoalkoxy-functional chalcones
|
|
PE20040522A1
(es)
|
2002-05-29 |
2004-09-28 |
Novartis Ag |
Derivados de diarilurea dependientes de la cinasa de proteina
|
|
IL165863A0
(en)
*
|
2002-06-24 |
2006-01-15 |
Schering Corp |
Indole derivatives useful as histamine H3 antagonists
|
|
AU2003243921B2
(en)
|
2002-06-27 |
2009-05-07 |
Novo Nordisk A/S |
Aryl carbonyl derivatives as therapeutic agents
|
|
WO2004013102A1
(de)
|
2002-07-31 |
2004-02-12 |
Schering Aktiengesellschaft |
Vegfr-2 und vegfr-3 inhibitorische anthranylamidpyrimidene
|
|
GB0218147D0
(en)
|
2002-08-05 |
2002-09-11 |
Oxford Glycosciences Uk Ltd |
Novel compounds
|
|
JP4606876B2
(ja)
|
2002-08-27 |
2011-01-05 |
キッセイ薬品工業株式会社 |
ピラゾール誘導体、それを含有する医薬組成物及びその医薬用途
|
|
MXPA05002571A
(es)
|
2002-09-04 |
2005-09-08 |
Schering Corp |
Pirazolopirimidinas como inhibidores de cinasa dependientes de ciclina.
|
|
US6915814B2
(en)
*
|
2002-09-04 |
2005-07-12 |
Dara Cheng |
Transparent pipe trap with means of enhancing the biodegradation of sink effluents
|
|
CA2498291C
(en)
|
2002-09-10 |
2009-04-07 |
Pfizer Products Inc. |
Diazabicyclic compounds useful in the treatment of cns and other disorders
|
|
ES2287542T3
(es)
|
2002-10-29 |
2007-12-16 |
L'oreal |
Composicion capilar que contiene un compuesto estirilpirazol.
|
|
ATE552236T1
(de)
*
|
2003-01-14 |
2012-04-15 |
Cytokinetics Inc |
Verbindungen, zusammensetzungen und verfahren zur behandlung von herzinsuffizienz
|
|
US7557129B2
(en)
*
|
2003-02-28 |
2009-07-07 |
Bayer Healthcare Llc |
Cyanopyridine derivatives useful in the treatment of cancer and other disorders
|
|
US7531553B2
(en)
*
|
2003-03-21 |
2009-05-12 |
Amgen Inc. |
Heterocyclic compounds and methods of use
|
|
AU2003902073A0
(en)
*
|
2003-05-01 |
2003-05-15 |
Kevin Raymond Deguara |
A lighting substrate
|
|
WO2004098591A2
(en)
*
|
2003-05-05 |
2004-11-18 |
Probiodrug Ag |
Inhibitors of glutaminyl cyclase and their use in the treatment of neurological diseases
|
|
WO2004101529A1
(ja)
|
2003-05-19 |
2004-11-25 |
Ono Pharmaceutical Co., Ltd. |
含窒素複素環化合物およびその医薬用途
|
|
EP1636585B2
(en)
*
|
2003-05-20 |
2012-06-13 |
Bayer HealthCare LLC |
Diaryl ureas with kinase inhibiting activity
|
|
GB0316915D0
(en)
*
|
2003-07-18 |
2003-08-20 |
Glaxo Group Ltd |
Compounds
|
|
PE20051046A1
(es)
|
2003-11-28 |
2006-01-11 |
Novartis Ag |
Derivados de diaril-urea en el tratamiento de enfermedades dependientes de la quinasa de proteina
|
|
TW200530236A
(en)
|
2004-02-23 |
2005-09-16 |
Chugai Pharmaceutical Co Ltd |
Heteroaryl phenylurea
|
|
CA2564355C
(en)
|
2004-05-07 |
2012-07-03 |
Amgen Inc. |
Protein kinase modulators and method of use
|
|
ES2522579T3
(es)
*
|
2004-06-17 |
2014-11-17 |
Cytokinetics, Inc. |
Compuestos, composiciones y métodos
|
|
WO2006009729A2
(en)
|
2004-06-18 |
2006-01-26 |
Medtronic, Inc. |
Methods and devices for occlusion of an atrial appendage
|
|
US7176222B2
(en)
*
|
2004-07-27 |
2007-02-13 |
Cytokinetics, Inc. |
Syntheses of ureas
|
|
WO2006089871A2
(en)
|
2005-02-23 |
2006-08-31 |
Neurosearch A/S |
Diphenylurea derivatives useful as erg channel openers for the treatment of cardiac arrhythmias
|
|
US7538223B2
(en)
*
|
2005-08-04 |
2009-05-26 |
Cytokinetics, Inc. |
Compounds, compositions and methods
|
|
ES2419007T3
(es)
*
|
2005-12-15 |
2013-08-19 |
Cytokinetics, Inc. |
Ciertas entidades químicas, composiciones y procedimientos
|
|
US20070208000A1
(en)
|
2005-12-15 |
2007-09-06 |
Morgan Bradley P |
Certain chemical entities, compositions and methods
|
|
US7825120B2
(en)
*
|
2005-12-15 |
2010-11-02 |
Cytokinetics, Inc. |
Certain substituted ((piperazin-1-ylmethyl)benzyl)ureas
|
|
EP1959947A2
(en)
*
|
2005-12-15 |
2008-08-27 |
Cytokinetics, Inc. |
Certain chemical entities, compositions and methods
|
|
WO2007078815A2
(en)
*
|
2005-12-16 |
2007-07-12 |
Cytokinetics, Inc. |
Certain chemical entities, compositions, and methods
|
|
WO2007078839A2
(en)
|
2005-12-19 |
2007-07-12 |
Cytokinetics, Inc. |
Compounds, compositions and methods
|
|
US7672247B2
(en)
*
|
2006-02-23 |
2010-03-02 |
International Business Machines Corporation |
Evaluating data processing system health using an I/O device
|
|
SG11201507258PA
(en)
|
2013-03-14 |
2015-10-29 |
Amgen Inc |
Heterocyclic compounds and their uses
|
|
US9895308B2
(en)
|
2013-03-14 |
2018-02-20 |
Amgen Inc. |
Heterocyclic compounds and their uses
|
|
US10543215B2
(en)
|
2015-06-26 |
2020-01-28 |
Amgen Inc. |
Combination therapy of cardiac myosin activator and sinus node if current inhibitor
|
|
CN105572945B
(zh)
|
2016-03-10 |
2019-06-14 |
京东方科技集团股份有限公司 |
阵列基板、偏光片贴附膜及其制备方法
|
|
AU2018294254C1
(en)
|
2017-06-30 |
2022-10-13 |
Amgen Inc. |
Synthesis of omecamtiv mecarbil
|
|
PT3594199T
(pt)
|
2018-07-09 |
2020-09-04 |
Amgen Inc |
2-fluoro-3-nitrotolueno cristalino e processo para a sua preparação
|
|
MA53226A
(fr)
|
2018-08-17 |
2021-11-24 |
Amgen Inc |
Sel et formes cristallines d'omecamtiv mecarbil
|
|
WO2020131574A1
(en)
|
2018-12-18 |
2020-06-25 |
Amgen Inc. |
Method of reducing aromatic nitro compounds
|
|
US20230090391A1
(en)
|
2020-02-10 |
2023-03-23 |
Amgen Inc. |
Omecamtiv mecarbil tablet
|
|
DK4243825T3
(da)
|
2020-11-12 |
2025-12-01 |
Amgen Inc |
Omecamtiv mecarbil til behandling af hjerteinsattsvigt hos udvalgte patientgrupper
|
|
IL305751A
(en)
|
2021-03-10 |
2023-11-01 |
Amgen Inc |
SYNTHESIS OF OMECAMTIV MECARBIL
|
|
US11986474B1
(en)
|
2023-06-27 |
2024-05-21 |
Cytokinetics, Incorporated |
Methods for treating heart failure by administering cardiac sarcomere activators
|